Eurobio Scientific Société anonyme (EPA:ALERS)

Market Cap	251.09M
Revenue (ttm)	154.90M
Net Income (ttm)	4.00M
Shares Out	10.04M
EPS (ttm)	n/a
PE Ratio	62.77
Forward PE	21.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	339
Average Volume	839
Open	25.00
Previous Close	25.38
Day's Range	25.00 - 25.00
52-Week Range	13.80 - 26.50
Beta	0.40
RSI	53.79
Earnings Date	Apr 11, 2025

About EPA:ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the ev...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 320
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALERS

Financial Performance

In 2023, EPA:ALERS's revenue was 130.65 million, a decrease of -14.55% compared to the previous year's 152.90 million. Earnings were 4.84 million, a decrease of -80.61%.